Session Datesort ascending
Comparison of Cystatin C and Creatinine in the Assessment of Measured Kidney Function during Critical Illness 06/30/2023 - 12:00pm to 1:00pm
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active controlled clinical trial & Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease–Mineral and Bone Disease (CKD-MBD) Mar 06/16/2023 - 12:00pm to 1:00pm
Ultrafiltration Rate Levels in Hemodialysis Patients Associated with Weight-Specific Mortality Risks 06/09/2023 - 12:00pm to 1:00pm
The Effect of Magnesium Supplementation on Vascular Calcification in CKD: A Randomized Clinical Trial (MAGiCAL-CKD) & Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes 05/19/2023 - 12:00pm to 1:00pm
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants & Tubular Epithelial Cell HMGB1 Promotes AKI-CKD Transition by Sensitizing Cycling Tubular Cells to Oxidative Stress: A Rationale for Targeting HMGB1 during AKI Recovery 04/21/2023 - 12:00pm to 1:00pm
TMA and Kidney Transplant 04/14/2023 - 12:00pm to 1:00pm
Role of Genomics in Kidney Transplantation 04/07/2023 - 12:00pm to 1:00pm
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension 03/10/2023 - 12:00pm to 1:00pm
Risk of Symptomatic Kidney Stones During and After Pregnancy 02/17/2023 - 12:00pm to 1:00pm
A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis 01/20/2023 - 12:00pm to 1:00pm

Pages